Maryland Subject | Opioids

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDHB116PassRequiring local correctional facilities to conduct an assessment of the mental health and substance use status of each inmate using evidence-based screenings and assessments to determine if a certain diagnosis is appropriate and if medication-assiste...
[Detail][Text][Discuss]
2019-05-13
Approved by the Governor - Chapter 532
MDHB1274PassEstablishing the Opioid Restitution Fund as a special, nonlapsing fund which consists of all revenue received by the State from any source resulting, directly or indirectly, from any judgement against or settlement with, opioid manufacturers, opioid ...
[Detail][Text][Discuss]
2019-05-13
Approved by the Governor - Chapter 537
MDHB751PassRequiring certain insurers, health service plans, and health maintenance organizations to allow a health care provider to indicate whether a prescription drug is to be used to treat a chronic condition; prohibiting an entity from requesting a reautho...
[Detail][Text][Discuss]
2019-05-13
Approved by the Governor - Chapter 549
MDSB631PassRequiring an insurer, nonprofit health service plan, or health maintenance organization to use the most recent treatment criteria developed by the American Society of Addiction Medicine for addictive, substance-related, and co-occurring conditions fo...
[Detail][Text][Discuss]
2019-04-30
Approved by the Governor - Chapter 357
MDHB847IntroRequiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or the designee of the medical director of Medicaid managed care organizations for the purpos...
[Detail][Text][Discuss]
2019-03-28
Unfavorable Report by Health and Government Operations; Withdrawn
MDSB135IntroAuthorizing the establishment of an Overdose and Infectious Disease Prevention Site Program by a community-based organization to provide a place for the consumption of preobtained drugs, provide sterile needles, administer first aid, and provide cert...
[Detail][Text][Discuss]
2019-03-27
Unfavorable Report by Finance; Withdrawn
MDSB846EngrossRequiring local correctional facilities to conduct an assessment of the mental health and substance use status of each inmate using evidence-based screening and assessments to determine whether opioid treatment or medication-assisted treatment for op...
[Detail][Text][Discuss]
2019-03-27
Hearing 4/02 at 1:00 p.m. (Judiciary)
MDSB893EngrossEncouraging the Natalie M. LaPrade Medical Cannabis Commission to approve provider applications for patients who have an opioid use disorder only if the patient has unsuccessfully tried all other traditional treatments or the patient will use the med...
[Detail][Text][Discuss]
2019-03-19
To House Health and Government Operations Committee
MDHB139IntroAuthorizing the establishment of an Overdose and Infectious Disease Prevention Site Program by a community-based organization to provide a place for the consumption of preobtained drugs, provide sterile needles, administer first aid, and provide cert...
[Detail][Text][Discuss]
2019-03-16
Unfavorable Report by Health and Government Operations; Withdrawn
MDHB142IntroRequiring a local department of social services, if appropriate, to monitor an opioid-exposed newborn through a certain mobile application under certain circumstances; requiring a local department to assess the risk of harm to and safety of an opioid...
[Detail][Text][Discuss]
2019-03-15
Unfavorable Report by Health and Government Operations; Withdrawn
MDSB498IntroRequiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or the designee of the medical director of Medicaid managed care organizations for the purpos...
[Detail][Text][Discuss]
2019-03-15
Unfavorable Report by Finance; Withdrawn
MDHB337IntroProhibiting the distribution of a certain opioid or opioid analogue, the use of which causes the death of a minor; establishing a penalty of up to 30 years imprisonment for a violation of the Act; clarifying that certain conduct constitutes distribut...
[Detail][Text][Discuss]
2019-03-14
Unfavorable Report by Judiciary
MDSB570IntroProhibiting a person from distributing fentanyl, any structural variation of fentanyl, or any analogue of fentanyl, the use of which is a contributing cause of the death of another; establishing penalties for a violation of the Act; and providing tha...
[Detail][Text][Discuss]
2019-03-13
Unfavorable Report by Judicial Proceedings
MDHB1392IntroAuthorizing a prescribing licensed health care provider to co-prescribe or prescribe or a pharmacist to dispense an opioid overdose reversal drug under certain circumstances; prohibiting a prescribing licensed health care provider and pharmacist from...
[Detail][Text][Discuss]
2019-02-25
To House Rules and Executive Nominations Committee
MDHB35IntroRequiring an opioid maintenance therapy program to have a medical director who is a physician and has 2 years of experience providing services to individuals who are addicted to alcohol or other drugs, including at least 1 year of experience in the t...
[Detail][Text][Discuss]
2019-02-18
Unfavorable Report by Health and Government Operations; Withdrawn
MDSB312IntroProhibiting an insurer, based solely on information about the purchase or possession of an opioid overdose reversal drug by an applicant or insured or a prescription for an opioid overdose reversal drug prescribed to an applicant or insured, from tak...
[Detail][Text][Discuss]
2019-02-11
To Senate Finance Committee
MDSB531IntroRequiring the owner or operator of a storage warehouse, in accordance with certain provisions of law, to obtain and store naloxone and certain related paraphernalia on the premises and to make naloxone available to individuals to administer to certai...
[Detail][Text][Discuss]
2019-02-11
To Senate Finance Committee
MDSB820IntroAuthorizing a prescribing licensed health care provider to co-prescribe or prescribe or a pharmacist to dispense an opioid overdose reversal drug under certain circumstances; prohibiting a prescribing licensed health care provider and pharmacist from...
[Detail][Text][Discuss]
2019-02-11
To Senate Finance Committee
MDHB33IntroEncouraging the Natalie M. LaPrade Medical Cannabis Commission to approve provider applications for patients who have an opioid use disorder.
[Detail][Text][Discuss]
2019-01-22
To House Health and Government Operations Committee
Syndicate content
feedback